TD completes acquisition of Cowen Inc. Learn more.

Marc Frahm, Ph.D.

Managing Director, Health Care - Biotechnology

Headshot photo of Marc Frahm

Prior to joining Cowen in July 2013, Marc Frahm was a graduate research assistant at Duke University. At Duke, he studied the T-cell response to HIV, the regulation of PD-L1 expression, and developed an in vitro diagnostic method for the differentiation of active and latent TB infections.

Dr. Frahm received a BS in biochemistry from the University of Wisconsin-Madison and his Ph.D. in molecular genetics and microbiology from Duke University.

Get In Touch

Start a conversation with Marc Frahm


    Explore related thought leadership, reports, coverage and insights for Marc Frahm.

    Closeup of pipetting sample in a lab setting
    Ahead of the Curve®

    Profoundly Expanding the Target Space: A Primer on TPD

    Petri dish of pills under FDA review. Representative of navigating FDA regulation post Covid.
    Ahead of the Curve®

    Trials & Triumphs of the FDA: What Matters? Where are We?

    Concept for targeted oncology of our own cells fighting cancer cells.
    Ahead of the Curve®

    Growing Up Ras: Resistance, Combos & Next Gen Agents